Basic Information
Basic information for ITGA9-AS1-232-95aa
Peptide Name ITGA9-AS1-232-95aa
Genome Position chr3:37694054-37694338[-]
Species Human
Peptide Sequence MKLFIYVKAEPRGGILKPPCDLKWTSAFLHHFLTADCRRKRPACLPGSFTQGWALPDARATGNPGEEIQTQAGGACSPPPSLVLSRRKGRACRSN
Peptide Length 95
Unique No (ITGA9-AS1-220-95aa)
Grand Average of Hydropathicity -0.4221
Relative Molecular Mass 12056.55
Experimental Evidences no
lncRNA ID/Name ENSG00000235257;ITGA9-AS1
Transcript ID/Name ENST00000663634;ITGA9-AS1-232
Transcript Length 1282
Coding Ability 0.5897
DNA Sequence Corresponding to Peptide ATGAAGCTTTTCATATACGTGAAAGCTGAGCCCCGCGGCGGAATACTGAAGCCGCCTTGTGATTTGAAATGGACATCTGCGTTTCTCCACCACTTCCTCACTGCCGACTGCCGCAGGAAGCGCCCAGCCTGTCTCCCAGGCAGTTTCACTCAAGGCTGGGCTCTCCCTGATGCAAGGGCCACAGGTAATCCAGGTGAGGAAATACAAACACAGGCTGGGGGTGCCTGCTCCCCGCCACCTTCTCTTGTCCTCTCAAGGAGGAAGGGAAGGGCCTGCAGAAGCAAC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :